Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

9.06
Delayed Data
As of 2:05pm ET
 -0.05 / -0.55%
Today’s Change
5.82
Today|||52-Week Range
11.34
+48.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues353.0K610.0K611.0K617.0K
 
 
 
 
 
Cost of Goods Sold489.0K186.0K--0.00
 
 
 
Depreciation And Amortization1.0K1.0K1.0K2.0K
 
 
 
 
 
 
Operating ExpensesGross Income-137.0K423.0K--615.0K
 
 
 
 
General Expenses3.4M2.8M4.0M2.8M
 
 
 
 
 
Research And Development2.8M2.4M3.1M2.3M
 
 
 
 
 
Total Operating Expenses3.9M3.0M4.0M2.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.5M-2.4M-3.4M-2.2M
 
 
 
 
 
Other Expenses-30.0K-24.0K-21.0K-20.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.4M-2.2M-3.2M-2.0M
 
 
 
 
 
Income Taxes-1.3M-400.0K0.000.00
 
 
 
Net Income-4.8M-2.6M-3.2M-2.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.2M13.2M13.3M13.3M
 
 
 
 
 
Shares To Calculate EPS Diluted13.2M13.2M13.3M13.3M
 
 
 
 
 
 
Earnings Per ShareEPS---$0.20-$0.24-$0.15
 
 
 
 
EPS Diluted-$0.36-$0.20-$0.24-$0.15